logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Serotonin and Norepinephrine Reuptake Inhibitor class drugs

    FiltersReset Filters
    17 results

    • desvenlafaxine

      (DESVENLAFAXINE)
      Advagen Pharma Ltd
      Usage: Desvenlafaxine extended-release tablets are indicated for the treatment of major depressive disorder (MDD) in adults.

    • desvenlafaxine

      (Desvenlafaxine)
      Hikma Pharmaceuticals USA Inc.
      Usage: Desvenlafaxine is indicated for the treatment of major depressive disorder (MDD) in adults.

    • desvenlafaxine

      (Desvenlafaxine)
      Slate Run Pharmaceuticals, LLC
      Usage: Desvenlafaxine is indicated for the treatment of adults with major depressive disorder (MDD).

    • desvenlafaxine succinate

      (Desvenlafaxine Succinate)
      Lupin Pharmaceuticals, Inc.
      Usage: Desvenlafaxine extended-release tablets are indicated for the treatment of adults with major depressive disorder (MDD).

    • duloxetine

      (Duloxetine Hydrochloride)
      Rising Pharma Holdings, Inc.
      Usage: Duloxetine delayed-release capsules are indicated for the treatment of major depressive disorder, generalized anxiety disorder (in adults and children 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.

    • duloxetine

      (Duloxetine)
      Ajanta Pharma USA Inc.
      Usage: Duloxetine delayed-release capsules are indicated for treating major depressive disorder, generalized anxiety disorder (in adults and pediatric patients 7+), diabetic peripheral neuropathic pain, fibromyalgia (in patients 13+), and chronic musculoskeletal pain in adults.

    • duloxetine hydrochloride

      (DULOXETINE HYDROCHLORIDE)
      Yaopharma Co., Ltd.
      Usage: Duloxetine delayed-release capsules are indicated for the treatment of Major Depressive Disorder, Generalized Anxiety Disorder, Diabetic Peripheral Neuropathy, and Chronic Musculoskeletal Pain.

    • effexor

      (VENLAFAXINE HYDROCHLORIDE)
      Viatris Specialty LLC
      Usage: Effexor XR is indicated for the treatment of Major Depressive Disorder (MDD), Generalized Anxiety Disorder (GAD), Social Anxiety Disorder (SAD), and Panic Disorder (PD) in adults.

    • fetzima

      (LEVOMILNACIPRAN HYDROCHLORIDE)
      Allergan, Inc.
      Usage: FETZIMA® is indicated for the treatment of major depressive disorder (MDD) in adults. It is not approved for fibromyalgia, and its efficacy and safety for that condition have not been established.

    • na

      (Duloxetine delayed-release capsules)
      Qingdao BAHEAL Pharmaceutical Co., Ltd.
      Usage: Duloxetine delayed-release capsules are indicated for treating Major Depressive Disorder, Generalized Anxiety Disorder (in adults and pediatric patients 7+), Diabetic Peripheral Neuropathic Pain, Fibromyalgia, and Chronic Musculoskeletal Pain in adults.